-
-
GLIADEL
- QTY 8
- 7.7-192.3
- WAFER
- Near 77381
CARMUSTINE, BCNU (kar MUS teen) is a chemotherapy drug. It interferes with the growth of rapidly growing cells like cancer cells. This medicine is used to treat glioma and glioblastoma. The wafers are placed at a site where a brain tumor used to be, at the end of a surgery to remove the tumor.
Change Location
Set Price Drop Alert for:
GLIADEL
- QTY 8
- 7.7-192.3
- WAFER
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
GLIADEL
- QTY 8
- 7.7-192.3
- WAFER
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Medicine Chest
GLIADEL Lifestyle Interactions
-
Phendimetrazine Tartrate 105mg, Oral capsule, extended release
• Interaction: Caffeine-containing Foods/Beverages• Severity: Moderate• Notes for Consumers: Limit caffeine intake (examples: coffee, teas, colas, chocolate and some herbal supplements) while taking Phendimetrazine. Also avoid medicines containing additional Caffeine whenever possible. Side effects from Phendimetrazine may get worse if you take excessive Caffeine. Taking a high amount of Caffeine can increase the risk of nausea, nervousness, palpitations, problems with sleep, rapid heartbeat, tremor, or other side effects.• Notes for Professionals: Caffeine is a CNS-stimulant and such actions are expected to be additive when coadministered with other CNS stimulants or psychostimulants.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
